FDA Approval of Durvalumab (AEGEAN Trial) : Episode 1
Overview of the AEGEAN Trial
Panelists discuss how the AEGEAN trial provides critical insights into the efficacy and safety of new therapeutic approaches, highlighting its design, key findings, and implications for future treatment strategies.
Related Content
